Please assess the completion status of the following clinical trial:

Trial Title: Botox for Non-surgical Lateral Release in Patellofemoral Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* retropatellar knee pain~* pain with two of: prolonged sitting, climbing stairs, squatting, running, kneeling, hopping, jumping~* pain with patellar palpation~* symptoms minimum 1 month~* Visual Analog Scale for pain (VAS) usual pain 4 of 10 on VAS \[0-10 scale, anchors 0 = no pain, 10 = worst pain imaginable\]~Exclusion Criteria:~* history knee surgery~* history patellar dislocation~* clinical evidence of meniscal lesion, ligamentous instability, traction apophysitis around the patellofemoral complex, patellar tendon pathology, chondral damage, osteoarthrosis, spinal referred pain

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Injection of Botulinum toxin A into vastus lateralis of study limb plus exercise program
- 2 (Type: PLACEBO_COMPARATOR): Placebo injection + exercise

Based on this trial design, predict the completion outcome and termination type (if applicable).